Search Videos and More
PP-007: A First-in-Class Neuroprotective Agent Moves into Phase 3 Stroke Trial
A novel investigational compound, PP-007 (PEGylated carboxyhemoglobin), is advancing to a global Phase 3 clinical trial as a potential breakthrough in the treatment of acute ischemic strokeFIU Health Physicians to Practice Under Baptist Health as Part of FIU Clinical and Academic Alliance
Baptist Health and Florida International University (FIU) Herbert Wertheim College of Medicine have formed a strategic alliance that aims to enhance patient care, physician training and clinical research in South Florida.New Study Shows Tiny Cuts Could Improve Brain Surgery: A Simpler, Safer Way to Treat Brain Tumors
A new study from doctors at Miami Neuroscience Institute, part of Baptist Health, highlights a gentler way to perform brain surgery, one that uses small tools and avoids the need for large openings in the skull.Baptist Health Brain & Spine Care Reaches New Heights with 250 HiFU Procedures
Recently, neurosurgeons at Miami Neuroscience Institute and Marcus Neuroscience Institute, both part of Baptist Health, hit new HiFU milestones, treating 200 and 50 patients respectively.Refer Patients Early When Brain and Spine Disorders Are Suspected
Experts at the inaugural Marcus Neuroscience Institute Brain & Spine Symposium shared the latest advances recently with physicians and other healthcare providers.Zapping Back Pain: Spinal Cord Stimulation Changes Patient’s Life
When back pain strikes, it can be unbearable. A small percentage of patients will also benefit from back surgery. But what happens when the pain persists even after doctors have tried nearly everything?Baptist Health Researchers Map How Radiation Rewires the Brain
New research connects changes in brain networks after radiotherapy to declines in memory and cognition.Evolving Advances in Brain Tumor Care: Insights from Medical and Radiation Oncology
Brain tumors remain among the most complex and challenging conditions we confront. There are over 120 histologically distinct tumor types, with survival outcomes varying drastically depending on molecular profile and location.Advanced Treatment Strategies for Medically Refractory Epilepsy: A Clinical Update
Medically refractory epilepsy remains a significant clinical challenge, affecting approximately 30 percent of the 3.4 million Americans living with epilepsy.Hormones and Seizures: What Every Woman with Epilepsy Should Know
Epilepsy affects more than 3 million women in the United States, and yet many are unaware that their hormones may be influencing their seizuresStroke and Pregnancy: A Potentially Deadly Combination
What most people don’t realize is that pregnancy places them at higher risk for stroke than they otherwise would be, not just during those nine months, but also in the weeks and months after giving birth.Marcus Neuroscience Institute, part of Baptist Health Launches GUIDE Program to Enhance Dementia Care
Marcus Neuroscience Institute, part of Baptist Health South Florida, located at Boca Raton Regional Hospital, is proud to announce its participation in the Guiding an Improved Dementia Experience (GUIDE) Model, a nationwide initiative designed to assist in the management of dementia care.
